These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 3488514)
41. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
42. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
44. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors. Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422 [TBL] [Abstract][Full Text] [Related]
45. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. Rosenzweig-Lipson S; Bergman J J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432 [TBL] [Abstract][Full Text] [Related]
46. Dopamine receptor subtypes and formalin test analgesia. Morgan MJ; Franklin KB Pharmacol Biochem Behav; 1991 Oct; 40(2):317-22. PubMed ID: 1687167 [TBL] [Abstract][Full Text] [Related]
47. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat. al-Tajir G; Chandler CJ; Starr BS; Starr MS Neuropharmacology; 1990 Jul; 29(7):657-61. PubMed ID: 1974713 [TBL] [Abstract][Full Text] [Related]
48. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237 [TBL] [Abstract][Full Text] [Related]
49. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors. Eilam D; Talangbayan H; Canaran G; Szechtman H Psychopharmacology (Berl); 1992; 106(4):447-54. PubMed ID: 1533720 [TBL] [Abstract][Full Text] [Related]
50. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C. Deveney AM; Waddington JL Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598 [TBL] [Abstract][Full Text] [Related]
51. Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists. Boyar WC; Altar CA J Neurochem; 1987 Mar; 48(3):824-31. PubMed ID: 2949060 [TBL] [Abstract][Full Text] [Related]
52. Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors. Andén NE; Grabowska-Andén M Acta Physiol Scand; 1988 Oct; 134(2):285-90. PubMed ID: 2852446 [TBL] [Abstract][Full Text] [Related]
53. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release? Starr M J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468 [TBL] [Abstract][Full Text] [Related]
54. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats. Rimondini R; Ferré S; Giménez-Llort L; Ogren SO; Fuxe K Eur J Pharmacol; 1998 Apr; 347(2-3):153-8. PubMed ID: 9653875 [TBL] [Abstract][Full Text] [Related]
55. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate. Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140 [TBL] [Abstract][Full Text] [Related]
56. Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome. Taylor JL; Rajbhandari AK; Berridge KC; Aldridge JW Brain Res; 2010 Mar; 1322():92-101. PubMed ID: 20114036 [TBL] [Abstract][Full Text] [Related]
57. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors. Starr MS; Starr BS Eur J Pharmacol; 1995 Apr; 277(2-3):151-8. PubMed ID: 7493603 [TBL] [Abstract][Full Text] [Related]
58. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390. Barasi S; Ben-Sreti MM; Clatworthy AL; Duggal KN; Gonzalez JP; Robertson J; Rooney KF; Sewell RD Br J Pharmacol; 1987 Jan; 90(1):15-22. PubMed ID: 3545350 [TBL] [Abstract][Full Text] [Related]
59. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists. Gandolfi O; Dall'olio R; Vaccheri A; Roncada P; Montanaro N Pharmacol Biochem Behav; 1988 Jun; 30(2):463-9. PubMed ID: 3262877 [TBL] [Abstract][Full Text] [Related]
60. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats. Longoni R; Spina L; Di Chiara G Life Sci; 1987 Nov; 41(18):2135-45. PubMed ID: 2959833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]